Validity of hemoglobin A1c for diagnosing diabetes among people with and without HIV in Uganda

Abstract

Sub-Saharan Africa (SSA) is facing a growing co-epidemic of chronic HIV infection and diabetes. Hemoglobin A1c (A1c) may underestimate glycemia among people living with HIV (PLWH). We estimated the validity of A1c to diagnose diabetes among PLWH and HIV-uninfected persons in rural Uganda. Data were derived from a cohort of PLWH and age- and gender-matched HIV-uninfected comparators. We compared A1c to fasting blood glucose (FBG) using Pearson correlations, regression models, and estimated the sensitivity and specificity of A1c for detecting diabetes with FBG ≥126 mg/dL as reference standard. Approximately half (48%) of the 212 participants were female, mean age of 51.7 years (SD = 7.0) at enrollment. All PLWH (n = 118) were on antiretroviral therapy for a median of 7.5 years with mean CD4 cell count of 442 cells/µL. Mean FBG (89.7 mg/dL) and A1c (5.6%) were not different between PLWH and HIV-uninfected (P > 0.50) groups, but the HIV-uninfected group had a higher prevalence of A1c >5.7% (33% vs. 20%, P = 0.024). We found a relatively strong correlation between A1c and FBG (r = 0.67). An A1c ≥6.5% had a poor sensitivity (46%, 95% CI 26–67%) but high specificity (98%, 95% CI 96–99%) for detecting diabetes. More work is needed to define an optimal A1c for screening diabetes in SSA.

Keywords

Hemoglobin A1c fasting blood glucose diabetes HIV sub-Saharan Africa

Get full access to this article

View all access options for this article.

References

International Diabetes Federation. IDF diabetes atlas. 7th ed., www.diabetesatlas.org/ (2017, accessed 23 April 2017).

Institute for Health Metrics and Evaluation. The global burden of disease: generating evidence, guiding policy – Sub-Saharan Africa Regional Edition, www.healthdata.org/policy-report/global-burden-disease-generating-evidence-guiding-policy-%E2%80%93-sub-saharan-africa-regional (2018, accessed 23 January 2018).

World Health Organization. HIV/AIDS, www.afro.who.int/health-topics/hivaids (2017, accessed 23 January 2018).

UNAIDS. UNAIDS. Chronic care of HIV and non-communicable diseases: How to leverage the HIV experience, http://files.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20110526_JC2145_Chronic_care_of_HIV.pdf (2011, accessed 23 January 2018).

NCD Risk Factor Collaboration (NCD-RisC) – Africa Working Group. Trends in obesity and diabetes across Africa from 1980 to 2014: an analysis of pooled population-based studies. Int J Epidemiol 2017; 46:1421–1432.

Hernandez-Romieu

Garg

Rosenberg

et al . Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010. BMJ Open Diab Res Care 2017; 5: e000304.

Frankel

McNaghten

Shapiro

et al . A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states. Open AIDS J 2012; 6: 67–76.

Centers for Disease Prevention and Control. About the National Health and Nutrition Examination Survey, www.cdc.gov/nchs/nhanes/about_nhanes.htm (2017, accessed 22 November 2018).

De Wit

Sabin

Weber

et al . Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care 2008; 31: 1224–1229.

10.

Kalra

Agrawal

et al . Understanding diabetes in patients with HIV/AIDS. Diabetol Metab Syndr 2011; 3: 2.

11.

American Diabetes Association. ADA diabetes management guidelines, www.ndei.org/ADA-diabetes-management-guidelines-diagnosis-A1C-testing.aspx.html (2016, accessed 25 April 2017).

12.

World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus, www.who.int/diabetes/publications/report-hba1c_2011.pdf?ua=1 (2011, accessed 15 April 2018).

13.

Wheeler

Leong

Liu

C-T

et al . Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis. PLoS Med 2017; 14: e1002383.

14.

Kim

S-Y

Friedmann

Seth

et al . Monitoring HIV-infected patients with diabetes: hemoglobin A1c, fructosamine, or glucose? Clin Med Insights Endocrinol Diabetes 2014; 7: 41–45.

15.

Kim

Woods

Georgoff

et al . A1C underestimates glycemia in HIV infection. Diabetes Care 2009; 32: 11591–11593.

16.

Guan

Zheng

Sun

et al . The changing relationship between HbA1c and FBG according to different FBG ranges. J Endocrinol Invest 2016; 39: 523–528.

17.

Ketema

Kibret

KT.

Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health 2015; 73: 43.

18.

Ramachandran

Riddle

Kabali

et al . ORIGIN investigators. Relationship between A1C and fasting plasma glucose in dysglycemia or type 2 diabetes: an analysis of baseline data from the ORIGIN trial. Diabetes Care 2012; 35: 749–753.

19.

Slama

Palella

Abraham

et al . Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters. J Antimicrob Chemother 2014; 69: 3360–3367.

20.

Feinstein

Kim

J-H

Bibangambah

et al . Ideal cardiovascular health and carotid atherosclerosis in a mixed cohort of HIV-infected and uninfected Ugandans. AIDS Res Hum Retroviruses 2017; 33: 49–56.

21.

Siedner

Kim

J-H

Nakku

et al . HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS Lond Engl 2016; 30: 667–670.

22.

ClinicalTrials.gov. Ugandan Non-Communicable Diseases and Aging Cohort (UGANDAC), https://clinicaltrials.gov/ct2/show/NCT02445079 (2017, accessed 16 February 2018).

23.

American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes – 2018. Diabetes Care 2018; 41:S13–S27.

24.

Bonora

Tuomilehto

The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011; 34: S184–S190.

25.

Karnchanasorn

Huang

H-Y

et al . Comparison of the current diagnostic criterion of HbA1c with fasting and 2-hour plasma glucose concentration. J Diabetes Res 2016; 2016: 6195494.

26.

Glesby

Hoover

Shi

et al . Glycated hemoglobin in diabetic women with and without HIV infection: data from the women’s interagency HIV study. Antivir Ther (Lond) 2010; 15: 571–577.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.12 MB